|
Patient
characteristics.
|
Patient
|
AMLa (FAB)
|
Age
(yr)
|
Sex
|
WBC (x109)
|
Blasts (%)
|
Karyotype
|
|
1
|
M0
|
70
|
M
|
2.6
|
60
|
46, X0
|
|
2
|
M1
|
63
|
F
|
4
|
50
|
t(8;21)
|
|
3
|
Sec. AML
|
64
|
M
|
1.6
|
80
|
normal
|
|
4
|
M2
|
85
|
F
|
26.8
|
52
|
inv(16)
|
|
5
|
M1
|
49
|
M
|
251
|
99
|
add(19)(p13)
|
|
6
|
Sec. AML
|
60
|
M
|
9.5
|
70
|
normal
|
|
7
|
M5a
|
45
|
F
|
150
|
90
|
normal
|
|
8
|
M3
|
44
|
F
|
113
|
97
|
46, XY del(20)(q11);
46, XY del(20)(q11) add(22)(p11);
47, XY del(20)(q11), +21
|
|
9
|
Sec. AML
|
75
|
M
|
6.4
|
80
|
normal
|
|
10
|
M0
|
68
|
F
|
153
|
99
|
46, XY
add8p
|
|
11
|
M2
|
68
|
M
|
4
|
60
|
normal
|
|
12
|
M4
|
51
|
M
|
23
|
52
|
normal
|
|
13
|
M4
|
64
|
F
|
84
|
80
|
normal
|
|
14
|
M5b
|
54
|
F
|
113
|
92
|
normal
|
|
15
|
M5
|
49
|
M
|
86
|
89
|
normal
|
aAbbreviation: Sec. AML, secondary AML.
|
